Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1366/week)
    • Manufacturing(679/week)
    • Energy(542/week)
    • Technology(1341/week)
    • Other Manufacturing(483/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

RELA

Apr 07, 2020
Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer
Dec 17, 2019
Kanazawa University Research: Possible Strategy for Cancer Treatment Found in Nuclear Transport Proteins
Dec 16, 2019
Gene Therapy Market to Garner $6.21 Bn, Globally, by 2026 at 34.8% CAGR, Says Allied Market Research
Aug 05, 2019
PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility
May 17, 2019
Countries Around the World to Shine a Light on NF on May 17, World NF Awareness Day
Feb 12, 2019
Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100(TM) for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities
Sep 25, 2018
OncoSec to Present at Cantor Fitzgerald Global Healthcare Conference
Mar 26, 2018
Infinity to Present at Two Upcoming Conferences
Dec 15, 2017
Cancer Gene Therapy Market achieve 20.7% growth to surpass $4.3 billion by 2024
Oct 27, 2017
The First Patient Enrolled in the ReITIrate Study Evaluating Immune Tolerance Induction With Elocta®
Oct 05, 2017
Tolero Pharmaceuticals to Deliver Keynote Presentations at the 9th International Conference on Leukemia and Hematologic Oncology
Sep 06, 2017
OncoSec Announces Presentations at Upcoming Investment and Scientific Conferences
Aug 02, 2017
Foundational Study Shows Soft Suit Exoskeleton Improves Walking for Stroke Survivors
Jun 21, 2017
Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe
Jun 02, 2017
OncoSec to Present at LD Micro Invitational

Latest News

May 17, 2025

IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes

May 17, 2025

Leeward Renewable Energy Operations Announces the Posting of an Update to its Year End 2024 Financial Results

May 17, 2025

Missouri American Water New Customer Rates Approved by Missouri Public Service Commission

May 17, 2025

Mayville Engineering Company Statement on Tornado Damage at Manufacturing Facility

May 17, 2025

Southern California Edison’s Wildfire Mitigation Plan Leverages Grid Innovations to Advance Community Safety

May 17, 2025

H&P Retains Eastdil Secured to Evaluate Future Options for Utica Square Shopping Center

May 17, 2025

Albany International Declares Dividend

May 17, 2025

Grove Receives NYSE Continued Listing Standards Notice

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
21
May
United KingdomLondon, UK
Space Operations Summit, 21 - 22 May 2025, London, UK
Space Operations Summit | 21 - 22 May, 2025 | London, UK Space Operations Summit 2025 is the only conference to look at...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia